Avalon Pharma secures CMA nod for 75% bonus capital boost

The Capital Market Authority (CMA) approved Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) capital top-up request by 75% through a 3-for-

You will be redirected in 10 seconds.

liveinternet liveinternet